Attitudes of Patients and Prescribing Clinicians to Polypharmacy and Medication Withdrawal in Heart Failure

Journal of Cardiac Failure

Volumn 22, Issue 9, 2016, Pages 743-744

  Hopper, Ingrid ^a,b   de Silva, Carolyn ^b   Skiba, Marina ^a,b   Tonkin, Andrew ^a   Krum, Henry ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b Clinical Pharmacology Unit   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; POTASSIUM; SPIRONOLACTONE; WARFARIN;

AUSTRALIA; CARDIOLOGIST; DISEASE CONTROL; DISEASE COURSE; DRUG COST; DRUG DOSE TITRATION; DRUG WITHDRAWAL; GENERAL PRACTITIONER; HEALTH CARE SURVEY; HEALTH PERSONNEL ATTITUDE; HEART FAILURE; HUMAN; IDIOPATHIC DISEASE; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; LETTER; MAJOR CLINICAL STUDY; NEW YORK HEART ASSOCIATION CLASS; NURSE PRACTITIONER; PATIENT ATTITUDE; PATIENT SATISFACTION; PATIENT WORRY; POLYPHARMACY; PRIORITY JOURNAL; QUESTIONNAIRE; SINUS RHYTHM; SURVIVAL; TREATMENT WITHDRAWAL; AGED; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG UTILIZATION; FEMALE; FOLLOW UP; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; MORTALITY; PATIENT PREFERENCE; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE;

AGED; ATTITUDE OF HEALTH PERSONNEL; AUSTRALIA; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT PREFERENCE; POLYPHARMACY; RISK ASSESSMENT; SURVEYS AND QUESTIONNAIRES; SURVIVAL RATE; WITHHOLDING TREATMENT;

EID: 84990946242     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2016.05.004     Document Type: Letter

References (8)

1. 1 Reeve, E., Wiese, M.D., Hendrix, I., Roberts, M.S., Shakib, S., People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc 61 (2013), 1508–1514.
2. 2 Benson, J., Britten, N., Patients’ decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ, 325, 2002, 873.
3. 3 Qi, K., Reeve, E., Hilmer, S.N., Pearson, S.A., Matthews, S., Gnjidic, D., Older peoples’ attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia. Int J Clin Pharm 37 (2015), 949–957.
4. 4 Fonarow, G.C., Stevenson, L.W., Walden, J.A., Livingston, N.A., Steimle, A.E., Hamilton, M.A., et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 30 (1997), 725–732.
5. 5 Riegel, B., Thomason, T., Carlson, B., Bernasconi, B., Clark, A., Hoagland, P., et al. Implementation of a multidisciplinary disease management program for heart failure patients. Congest Heart Fail 5 (1999), 164–170.
6. 6 Dunlay, S.M., Eveleth, J.M., Shah, N.D., McNallan, S.M., Roger, V.L., Medication adherence among community-dwelling patients with heart failure. Mayo Clin Proc, 86, 2011, 273.
7. 7 Henry, D.A., Hill, S.R., Harris, A., Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme. JAMA 294 (2005), 2630–2632.
8. 8 Hopper, I., Samuel, R., Hayward, C., Tonkin, A., Krum, H., Can medications be safely withdrawn in patients with stable chronic heart failure? systematic review and meta-analysis. J Card Fail 20 (2014), 522–532.